A new machine learning-driven feature analyzes therapy variables to help identify patients who may need additional clinical assessment.

Key takeaways:

  • Clinical Indicator Intelligence is a new feature within sovaGuide that uses machine learning to analyze multiple CPAP therapy variables.
  • The tool evaluates pressure alongside other variables to identify issues like elevated central apnea events, avoiding alerts based on pressure alone.
  • Notifications provide providers with a therapy summary and longitudinal usage history sourced from the CPAP manufacturer’s software.
  • The feature is designed to support clinical judgment, not replace it, and is currently available to eligible users.

SovaSage has released Clinical Indicator Intelligence, an enhanced feature within its sovaGuide platform designed to improve CPAP therapy management.

Using machine learning, the new capability continuously analyzes multiple CPAP therapy variables to help providers identify patients who may require additional clinical evaluation before therapy challenges lead to reduced benefit or treatment abandonment.

The enhancement improves the identification of patients experiencing elevated central apnea events and other therapy patterns that may indicate reduced treatment effectiveness. Elevated CPAP pressure alone does not generate a notification. Instead, sovaGuide evaluates pressure alongside additional therapy variables to provide a broader assessment of therapy performance.

“Patient engagement alone isn’t always enough,” says William Kaigler, CEO of sovaSage, in a release. “Some patients remain engaged but continue to struggle because their therapy is not achieving the desired clinical outcome. Clinical Indicator Intelligence helps providers recognize these patients earlier, allowing support before frustration leads to therapy discontinuation.”

Each notification includes a detailed therapy summary and longitudinal usage history sourced directly from the CPAP manufacturer’s clinical management software, giving providers immediate access to the clinical data supporting each alert.

The feature is designed to support—not replace—clinical judgment. All treatment decisions and patient management remain the responsibility of the treating clinician.

“Our mission has always been to combine artificial intelligence with behavioral science and clinical insight to improve patient outcomes,” says Kaigler in a release. “Clinical Indicator Intelligence represents another step toward delivering smarter, more proactive care that supports both providers and the patients they serve.”

Clinical Indicator Intelligence is now available to eligible sovaGuide customers.


More on SovaSage:

ID 94445709© Lochpalm| Dreamstime.com